Skip to main content
. 2020 Dec 7;15(12):e0243493. doi: 10.1371/journal.pone.0243493

Table 3. Drug resistance profiles for second-line drugs MDR-TB cases according to new cases and previously treated cases (n = 14), 2020.

Drug resistance pattern Isolates from new cases, n (%) Isolates from previously treated cases, n (%) Total n (%)
Total Isolate 11 3 14
Amikacin - - -
Capromycin 1(9.1) - 1 (7.1)
Ethionamide 1(9.1) - 1(7.1)
Kanamycin - - -
Ofloxacin 1(9.1) 1(33.3) 2 (14.3)
Moxifloxacin 1(9.1) 1(33.3) 2 (14.3)
Pre-XDR 2(18.2) 1(33.3) 3 (21.4)

XDR-Extensively Drug-Resistant.